发明名称 PROCESS FOR PRODUCING PHARMACEUTICAL COMPOSITIONS COMPRISING SULFATED CYCLODEXTRIN AND REDUCING THE ACTIVITY OF TERATOGENS ON EMBRYO
摘要 By administration of sulfated cyclodextrin on a pregnant mother, the effect of a teratogen on a developing fetus is blocked. Blocking the effect of the teratogen reduces congenital defects in a developing fetus. The sulfated cyclodextrin has also been found to reduce the effect of the teratogen on a host. The sulfated cyclodextrin is administered either before or after onset of organogenesis and either before or after exposure to the teratogen. Teratogens include radiation, temperature extremes, chemicals, drugs, bacteria, viruses, hormones, stress, injury, pregnancy, and fatigue.
申请公布号 HUT63333(A) 申请公布日期 1993.08.30
申请号 HUP9203498 申请日期 1991.05.07
申请人 AMERICAN MAIZE-PRODUCTS CO.,US 发明人 GEBER,WILLIAM F.,US
分类号 A61K31/715;A61K31/70 主分类号 A61K31/715
代理机构 代理人
主权项
地址